ArticleInflammatory bowel diseases2023

Quantitative Fecal Microbiota Profiles Relate to Therapy Response During Induction With Tumor Necrosis Factor α Antagonist Infliximab in Pediatric Inflammatory Bowel Disease.

Miikka Höyhtyä et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.